Citadel Advisors’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-69,746
| Closed | -$15K | – | 10521 |
|
|
2018
Q3 | $15K | Sell |
69,746
-66,297
| -49% | -$15.3K | ﹤0.01% | 9072 |
|
|
2018
Q2 | $35K | Sell |
136,043
-258,612
| -66% | -$67.2K | ﹤0.01% | 8527 |
|
|
2018
Q1 | $99K | Buy |
+394,655
| New | +$109K | ﹤0.01% | 7717 |
|
|
2016
Q3 | – | Sell |
-1,051
| Closed | -$10K | – | 8648 |
|
|
2016
Q2 | $10K | Sell |
1,051
-2,176
| -67% | -$22.4K | ﹤0.01% | 6731 |
|
|
2016
Q1 | $37K | Buy |
+3,227
| New | +$36.3K | ﹤0.01% | 6332 |
|
|
2015
Q3 | – | Sell |
-290
| Closed | -$5K | – | 9800 |
|
|
2015
Q2 | $5K | Buy |
+290
| New | +$5.58K | ﹤0.01% | 8557 |
|
|
2015
Q1 | – | Sell |
-1,465
| Closed | -$43K | – | 9402 |
|
|
2014
Q4 | $43K | Buy |
1,465
+912
| +165% | +$26.2K | ﹤0.01% | 7321 |
|
|
2014
Q3 | $20K | Sell |
553
-162
| -23% | -$6.24K | ﹤0.01% | 7464 |
|
|
2014
Q2 | $32K | Buy |
715
+623
| +677% | +$30.1K | ﹤0.01% | 7055 |
|
|
2014
Q1 | $5K | Sell |
92
-1,776
| -95% | -$86.9K | ﹤0.01% | 7672 |
|
|
2013
Q4 | $69K | Buy |
1,868
+1,462
| +360% | +$138K | ﹤0.01% | 5872 |
|
|
2013
Q3 | $42K | Buy |
+406
| New | +$44.6K | ﹤0.01% | 5891 |
|